Literature DB >> 24737329

Reconciling the structural attributes of avian antibodies.

Paul J Conroy1, Ruby H P Law1, Sarah Gilgunn2, Stephen Hearty3, Tom T Caradoc-Davies4, Gordon Lloyd1, Richard J O'Kennedy5, James C Whisstock6.   

Abstract

Antibodies are high value therapeutic, diagnostic, biotechnological, and research tools. Combinatorial approaches to antibody discovery have facilitated access to unique antibodies by surpassing the diversity limitations of the natural repertoire, exploitation of immune repertoires from multiple species, and tailoring selections to isolate antibodies with desirable biophysical attributes. The V-gene repertoire of the chicken does not utilize highly diverse sequence and structures, which is in stark contrast to the mechanism employed by humans, mice, and primates. Recent exploitation of the avian immune system has generated high quality, high affinity antibodies to a wide range of antigens for a number of therapeutic, diagnostic and biotechnological applications. Furthermore, extensive examination of the amino acid characteristics of the chicken repertoire has provided significant insight into mechanisms employed by the avian immune system. A paucity of avian antibody crystal structures has limited our understanding of the structural consequences of these uniquely chicken features. This paper presents the crystal structure of two chicken single chain fragment variable (scFv) antibodies generated from large libraries by phage display against important human antigen targets, which capture two unique CDRL1 canonical classes in the presence and absence of a non-canonical disulfide constrained CDRH3. These structures cast light on the unique structural features of chicken antibodies and contribute further to our collective understanding of the unique mechanisms of diversity and biochemical attributes that render the chicken repertoire of particular value for antibody generation.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antibody Engineering; Cardiac Troponin I; Cardiovascular Disease; Chicken; Prostate Cancer; Prostate-specific Antigen; Recombinant Antibody; Recombinant Protein Expression; Surface Plasmon Resonance (SPR); X-ray Crystallography

Mesh:

Substances:

Year:  2014        PMID: 24737329      PMCID: PMC4140895          DOI: 10.1074/jbc.M114.562470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Light-chain shuffling from an antigen-biased phage pool allows 185-fold improvement of an anti-halofuginone single-chain variable fragment.

Authors:  Jenny Fitzgerald; Paul Leonard; Elaine Darcy; Martin Danaher; Richard O'Kennedy
Journal:  Anal Biochem       Date:  2010-11-13       Impact factor: 3.365

2.  A new clustering of antibody CDR loop conformations.

Authors:  Benjamin North; Andreas Lehmann; Roland L Dunbrack
Journal:  J Mol Biol       Date:  2010-10-28       Impact factor: 5.469

3.  Conformations of the third hypervariable region in the VH domain of immunoglobulins.

Authors:  V Morea; A Tramontano; M Rustici; C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

4.  Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region.

Authors:  C A Reynaud; A Dahan; V Anquez; J C Weill
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

5.  Methods for the generation of chicken monoclonal antibody fragments by phage display.

Authors:  J Andris-Widhopf; C Rader; P Steinberger; R Fuller; C F Barbas
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Natural and man-made V-gene repertoires for antibody discovery.

Authors:  William J J Finlay; Juan C Almagro
Journal:  Front Immunol       Date:  2012-11-15       Impact factor: 7.561

9.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  9 in total

Review 1.  Structural and genetic diversity in antibody repertoires from diverse species.

Authors:  Miguel de los Rios; Michael F Criscitiello; Vaughn V Smider
Journal:  Curr Opin Struct Biol       Date:  2015-07-17       Impact factor: 6.809

2.  Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes.

Authors:  Hiromasa Yagi; Paul J Conroy; Eleanor W W Leung; Ruby H P Law; Joseph A Trapani; Ilia Voskoboinik; James C Whisstock; Raymond S Norton
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

3.  Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains.

Authors:  Jinhui Dong; Jessica A Finn; Peter A Larsen; Timothy P L Smith; James E Crowe
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

4.  Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement.

Authors:  Kyle L O'Donnell; Bernadette Meberg; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  Viruses       Date:  2019-03-26       Impact factor: 5.048

5.  Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.

Authors:  Brittney S Harrington; Yaowu He; Tashbib Khan; Simon Puttick; Paul J Conroy; Thomas Kryza; Tahleesa Cuda; Kamil A Sokolowski; Brian Wc Tse; Katherine K Robbins; Buddhika J Arachchige; Samantha J Stehbens; Pamela M Pollock; Sarah Reed; S John Weroha; Paul Haluska; Carlos Salomon; Rohan Lourie; Lewis C Perrin; Ruby H P Law; James C Whisstock; John D Hooper
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

6.  Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model.

Authors:  Aymn T Abbas; Sherif A El-Kafrawy; Sayed Sartaj Sohrab; Ashraf A Tabll; Ahmed M Hassan; Naoko Iwata-Yoshikawa; Noriyo Nagata; Esam I Azhar
Journal:  Vaccines (Basel)       Date:  2020-11-01

7.  Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y.

Authors:  Sarah Gilgunn; Silvia Millán Martín; Mark R Wormald; Julia Zapatero-Rodríguez; Paul J Conroy; Richard J O'Kennedy; Pauline M Rudd; Radka Saldova
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

8.  Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.

Authors:  Navasona Krishnan; Christopher A Bonham; Ioana A Rus; Om Kumar Shrestha; Carla M Gauss; Aftabul Haque; Ante Tocilj; Leemor Joshua-Tor; Nicholas K Tonks
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

Review 9.  An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review.

Authors:  Rajeswari Somasundaram; Ankit Choraria; Michael Antonysamy
Journal:  Int Immunopharmacol       Date:  2020-06-03       Impact factor: 4.932

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.